Elutia awarded cardian rhythm management devices agreement with Premier

Elutia (ELUT) announced it has been awarded a national group purchasing agreement for Cardiac Rhythm Management Devices with Premier (PINC). Effective November 15, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the EluPro Antibiotic-Eluting BioEnvelope, the company said in a statement. “We are thrilled to bring EluPro to a broader audience through this new agreement with Premier,” said Dr. Randy Mills, Elutia’s CEO.